Apratoxins
are cytotoxic natural products originally isolated from
marine cyanobacteria that act by preventing cotranslational translocation
early in the secretory pathway to downregulate receptor levels and
inhibit growth factor secretion, leading to potent antiproliferative
activity. Through rational design and total synthesis of an apratoxin
A/E hybrid, apratoxin S4 (1a), we have previously improved
the antitumor activity and tolerability in vivo. Compound 1a and newly designed analogues apratoxins S7–S9 (1b–d), with various degrees of methylation at C34
(1b,c) or epimeric configuration at C30
(1d), were efficiently synthesized utilizing improved
procedures. Optimizations have been applied to the synthesis of key
intermediate aldehyde 7 and further include the application
of Leighton’s silanes and modifications of Kelly’s methods
to induce thiazoline ring formation in other crucial steps of the
apratoxin synthesis. Apratoxin S9 (1d) exhibited increased
activity with subnanomolar potency. Apratoxin S8 (1c)
lacks the propensity to be deactivated by dehydration and showed efficacy
in a human HCT116 xenograft mouse model.